^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Rectal Cancer |
| Drug: | Lonsurf (trifluridine/tipiracil) (Thymidine phosphorylase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/20/2020
Excerpt:
Rectal cancer:.Subsequent therapy…Trifluridine + tipiracil modified with the addition of ± bevacizumab
